Omega Healthcare Investors (NYSE:OHI) Issues Quarterly Earnings Results

Omega Healthcare Investors (NYSE:OHI - Get Free Report) issued its quarterly earnings data on Wednesday. The real estate investment trust reported $0.74 EPS for the quarter, beating the consensus estimate of $0.41 by $0.33, Zacks reports. Omega Healthcare Investors had a return on equity of 9.71% and a net margin of 38.65%. Omega Healthcare Investors updated its FY 2025 guidance to 2.900-2.980 EPS.

Omega Healthcare Investors Price Performance

Shares of NYSE OHI traded down $0.12 during trading on Friday, hitting $37.94. The company had a trading volume of 2,468,451 shares, compared to its average volume of 1,912,040. The firm has a market capitalization of $10.24 billion, a price-to-earnings ratio of 24.48, a price-to-earnings-growth ratio of 1.11 and a beta of 0.99. The stock has a fifty day simple moving average of $38.00 and a two-hundred day simple moving average of $39.09. The company has a quick ratio of 6.48, a current ratio of 7.07 and a debt-to-equity ratio of 1.02. Omega Healthcare Investors has a fifty-two week low of $29.17 and a fifty-two week high of $44.42.

Omega Healthcare Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Shareholders of record on Monday, February 10th will be given a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 7.06%. The ex-dividend date of this dividend is Monday, February 10th. Omega Healthcare Investors's dividend payout ratio is presently 172.90%.

Wall Street Analysts Forecast Growth

OHI has been the subject of a number of research analyst reports. BMO Capital Markets upgraded Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 price target for the company in a research note on Monday, December 9th. Royal Bank of Canada lifted their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a "sector perform" rating in a research note on Monday, November 11th. JMP Securities reiterated a "market perform" rating on shares of Omega Healthcare Investors in a report on Friday. Berenberg Bank assumed coverage on shares of Omega Healthcare Investors in a research note on Friday, October 18th. They issued a "buy" rating and a $45.00 price objective on the stock. Finally, Mizuho boosted their target price on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the company a "neutral" rating in a research report on Thursday, December 5th. Five equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Omega Healthcare Investors currently has a consensus rating of "Moderate Buy" and an average target price of $41.67.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.